- Trials with a EudraCT protocol (66)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
66 result(s) found for: Nerve Injury.
Displaying page 1 of 4.
EudraCT Number: 2009-016038-29 | Sponsor Protocol Number: LIDO-2009 | Start Date*: 2010-03-11 | ||||||||||||||||
Sponsor Name:Danish Pain Research Center | ||||||||||||||||||
Full Title: Topical lidocaine: Predictors of response in peripheral nerve damage | ||||||||||||||||||
Medical condition: Neuropathic pain due to Peripheral nerve damage | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002083-25 | Sponsor Protocol Number: LIDO2011 | Start Date*: 2011-12-05 | ||||||||||||||||
Sponsor Name:BG University Hospital Bergmannsheil GmbH | ||||||||||||||||||
Full Title: Is there a correlation between the pain relief and the A-delta- and C-fiber function after topical application of lidocaine (5%) in patients with peripheral neuropathic pain? | ||||||||||||||||||
Medical condition: Patients with proven diagnosis of painful peripheral neuropathic pain syndromes as diagnosed as: 1. Peripheral nerve lesion or 2. Postherpetic neuralgia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002114-11 | Sponsor Protocol Number: SER-LEV-2004-01 | Start Date*: 2005-05-09 |
Sponsor Name:Infociencia Clinical Research | ||
Full Title: A double blind, randomized, placebo-controlled, cross-over study to evaluate the effects of Levetiracetam on membrane excitability properties of afferent myelinated and unmyelinated fibers and chan... | ||
Medical condition: Neuropathic pain due to a traumatic nerve lesion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005802-29 | Sponsor Protocol Number: RD/505/06 | Start Date*: 2007-06-26 | ||||||||||||||||||||||||||
Sponsor Name:Gwent Healthcare NHS Trust | ||||||||||||||||||||||||||||
Full Title: Postoperative analgesia for Total knee replacement: A comparision between intrathecal morphine and peripheral nerve block. | ||||||||||||||||||||||||||||
Medical condition: Postoperative analgesia for Total Knee Replacement | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005717-80 | Sponsor Protocol Number: FAB117-CT-01 | Start Date*: 2016-05-29 | ||||||||||||||||
Sponsor Name:Ferrer Internacional S.A | ||||||||||||||||||
Full Title: Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipos... | ||||||||||||||||||
Medical condition: Patients with acute traumatic spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004285-15 | Sponsor Protocol Number: SM2-PJ-11 | Start Date*: 2011-09-22 | |||||||||||
Sponsor Name:Professor Jørgen Berg Dahl | |||||||||||||
Full Title: A comparison of the efficacy of the Adductor-Canal-Blockade vs. the femoral nerve block on muscle strength and mobilization in healthy volunteers: a randomized study | |||||||||||||
Medical condition: Healthy volunteers (intended for postoperative pain treatment in patients after total knee arthroplasty) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015496-27 | Sponsor Protocol Number: Etoricox09-10 | Start Date*: 2010-03-15 | |||||||||||||||||||||||||||||||
Sponsor Name:BG university hospital Bergmannsheil GmbH | |||||||||||||||||||||||||||||||||
Full Title: Wirksamkeit von Etoricoxib bei Patienten mit neuropathischen Schmerzen mit und ohne peripherer Hyperalgesie (Efficacy of etoricoxibe in patients with neuropathic pain with and without peripheral hy... | |||||||||||||||||||||||||||||||||
Medical condition: Animal experiments analysing anti-hyperalgesic effects of Coxibs show inconsistent results due to different used dosages and varying different pain models. Theoretical the use of NSAIDs is rational... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010091-17 | Sponsor Protocol Number: KIP112967 | Start Date*: 2009-09-15 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury. Estudio aleatorizado, do... | |||||||||||||
Medical condition: Neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001227-31 | Sponsor Protocol Number: NISCI | Start Date*: 2019-06-19 | ||||||||||||||||
Sponsor Name:University Zurich, University Hospital Balgrist, Spinal Cord Injury Center | ||||||||||||||||||
Full Title: Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury | ||||||||||||||||||
Medical condition: spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002185-51 | Sponsor Protocol Number: Poplitea2017 | Start Date*: 2017-10-18 | |||||||||||
Sponsor Name:Tampere University Hospital | |||||||||||||
Full Title: Effect of perineural dexamethasone on the duration of popliteal nerve block for analgesia after ankle surgery | |||||||||||||
Medical condition: Ankle arthrosis, situation after ankle injury or malposition of ankle/foot, arthrodesis as a curative therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005684-24 | Sponsor Protocol Number: CME-LEM2 | Start Date*: 2014-01-16 | |||||||||||
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | |||||||||||||
Full Title: Subarachnoid administration of autologous bone marrow stromal cells in incomplete spinal cord injury. | |||||||||||||
Medical condition: Incomplete spinal cord injury, due to traumatical or ischemic cause. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002846-21 | Sponsor Protocol Number: PARENTIDE-02 | Start Date*: 2017-04-10 |
Sponsor Name:BCN Peptides S.A. | ||
Full Title: CLINICAL TRIAL PHASE IIa PROOF OF CONCEPT, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED IN PATIENTS WITH NEUROPATHIC PAIN DUE TO PERIPHERAL NERVE INJURY | ||
Medical condition: Patients with neuropathic pain due to peripheral nerve injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-003077-26 | Sponsor Protocol Number: IMIVER | Start Date*: 2012-08-13 | |||||||||||
Sponsor Name:Department of Neurology, Odense University Hospital | |||||||||||||
Full Title: Topical lidocaine for the treatment of focal peripheral neuropathic pain: response in relation to pain phenotype | |||||||||||||
Medical condition: Chronic peripheral neuropathic pain caused by postherpetic neuralgia and traumatic/surgical nerve injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000557-35 | Sponsor Protocol Number: NW-1029/001/II/2003 | Start Date*: 2005-06-09 |
Sponsor Name:Newron Pharmaceuticals SpA | ||
Full Title: A phase II, multi centre, pilot, randomised, ascending dose, double -blind, placebo controlled, dose titration study to determine the safety, maximum tolerated dose and preliminary evidence of effi... | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002282-35 | Sponsor Protocol Number: rh-NGF | Start Date*: 2020-05-13 | |||||||||||
Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
Full Title: Nerve growth factor in pediatric severe traumatic brain injury : translational and clinical studies on a candidate biomarker and therapeutic drug | |||||||||||||
Medical condition: Persistent unresponsive wakefulness syndrome (UWS) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000321-41 | Sponsor Protocol Number: ALENDROHNP2011 | Start Date*: 2012-04-18 | |||||||||||
Sponsor Name:FUNDACION HOSPITAL NACIONAL DE PARAPLEJICOS PARA LA INVESTIGACIÓN Y LA INTEGRACIÓN | |||||||||||||
Full Title: PREVENTIVE TREATMENT OF BONE MASS LOSS WITH ALENDRONATE AND CALCIFEDIOL IN PATIENTS WITH ACUTE SPINAL CORD INJURY | |||||||||||||
Medical condition: Preventing loss of bone density in patients with spinal cord injury of traumatic etiology complete during the first year of evolution of the lesion. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002764-12 | Sponsor Protocol Number: I12019 | Start Date*: 2013-08-05 | |||||||||||
Sponsor Name:University Hospital, Limoges | |||||||||||||
Full Title: The Pectoral Nerve Block (PECBLOCK) for the Treatment of Pain After Breast Cancer Surgery. | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004980-39 | Sponsor Protocol Number: Amiloride02 | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A double blind randomised controlled trial on neuroprotection of amiloride in optic neuritis | |||||||||||||
Medical condition: Optic Neuritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016457-18 | Sponsor Protocol Number: E05-CL-3001 | Start Date*: 2010-07-20 | |||||||||||
Sponsor Name:Astellas Pharma Europe Ltd | |||||||||||||
Full Title: A Multicentre, Single-Arm, Open-Label Study Of The Repeated Administration Of QUTENZA For The Treatment Of Peripheral Neuropathic Pain | |||||||||||||
Medical condition: Peripheral Neuropathic Pain in Postherpetic Neuralgia (PHN), Painful HIV-Associated Neuropathy (HIV-AN), Peripheral Neuropathic Injury (PNI), Idiopathic Small Nerve Neuropathy (ISNN) or other Perip... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) FR (Completed) BE (Completed) GB (Completed) CZ (Completed) FI (Completed) ES (Completed) AT (Completed) IT (Completed) HU (Completed) NL (Completed) SK (Completed) PL (Completed) SI (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.